PMCID	SUBJECT_SCOPE_ID	S_START	S_END	SUBJECT_SCOPE	CONCEPT	IGNORANCE TYPE	C_START	C_END	CONCEPT_MENTION_ID
PMC3348565	PMC3348565.nxml.gz-3	[0]	[152]	Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial	Effect	SUPERFICIAL_RELATIONSHIP	[0]	[6]	PMC3348565.nxml.gz-1
PMC3348565	PMC3348565.nxml.gz-5	[182]	[303]	Vitamin D has a role in regulating immune function, and its deficiency is a suggested risk factor for childhood pneumonia	role	SUPERFICIAL_RELATIONSHIP	[198]	[202]	PMC3348565.nxml.gz-6
PMC3348565	PMC3348565.nxml.gz-5	[182]	[303]	Vitamin D has a role in regulating immune function, and its deficiency is a suggested risk factor for childhood pneumonia	suggested	INCOMPLETE_EVIDENCE	[258]	[267]	PMC3348565.nxml.gz-7
PMC3348565	PMC3348565.nxml.gz-8	[305]	[471]	Our aim was to assess whether oral supplementation of vitamin D3(cholecalciferol) will reduce the incidence and severity of pneumonia in a high-risk infant population	aim	QUESTION_ANSWERED_BY_THIS_WORK	[309]	[312]	PMC3348565.nxml.gz-9
PMC3348565	PMC3348565.nxml.gz-8	[305]	[471]	Our aim was to assess whether oral supplementation of vitamin D3(cholecalciferol) will reduce the incidence and severity of pneumonia in a high-risk infant population	to assess	QUESTION_ANSWERED_BY_THIS_WORK	[317]	[326]	PMC3348565.nxml.gz-10
PMC3348565	PMC3348565.nxml.gz-8	[305]	[471]	Our aim was to assess whether oral supplementation of vitamin D3(cholecalciferol) will reduce the incidence and severity of pneumonia in a high-risk infant population	whether	ALTERNATIVE_OPTIONS_CONTROVERSY	[327]	[334]	PMC3348565.nxml.gz-14401
PMC3348565	PMC3348565.nxml.gz-8	[305]	[471]	Our aim was to assess whether oral supplementation of vitamin D3(cholecalciferol) will reduce the incidence and severity of pneumonia in a high-risk infant population	will	FUTURE_PREDICTION	[387]	[391]	PMC3348565.nxml.gz-13
PMC3348565	PMC3348565.nxml.gz-14	[1421]	[1619]	From 652 children during five separate periods of testing serum calcifediol, only one child in each of two testing periods had results greater than 375 nmol/L in the intervention group—a toxic level	only	ANOMALY_CURIOUS_FINDING	[1498]	[1502]	PMC3348565.nxml.gz-15
PMC3348565	PMC3348565.nxml.gz-16	[1863]	[2016]	Afghanistan has the third highest mortality of children younger than 5 years in the world (257 per 1000 livebirths); a leading cause of this is pneumonia	leading cause	IMPORTANT_CONSIDERATION	[1982]	[1995]	PMC3348565.nxml.gz-17
PMC3348565	PMC3348565.nxml.gz-18	[2018]	[2183]	Two hospital-based case-control studies in Ethiopia1and India2suggest that vitamin D deficiency might substantially increase the risk of severe pneumonia in children	suggest	INCOMPLETE_EVIDENCE	[2080]	[2087]	PMC3348565.nxml.gz-19
PMC3348565	PMC3348565.nxml.gz-18	[2018]	[2183]	Two hospital-based case-control studies in Ethiopia1and India2suggest that vitamin D deficiency might substantially increase the risk of severe pneumonia in children	might	INCOMPLETE_EVIDENCE	[2114]	[2119]	PMC3348565.nxml.gz-20
PMC3348565	PMC3348565.nxml.gz-18	[2018]	[2183]	Two hospital-based case-control studies in Ethiopia1and India2suggest that vitamin D deficiency might substantially increase the risk of severe pneumonia in children	severe	IMPORTANT_CONSIDERATION	[2155]	[2161]	PMC3348565.nxml.gz-21
PMC3348565	PMC3348565.nxml.gz-22	[2185]	[2366]	Our systematic review identified one randomised placebo controlled trial3relating pneumonia or lower respiratory infections to vitamin D deficiency supplementation in young children	relating	SUPERFICIAL_RELATIONSHIP	[2258]	[2266]	PMC3348565.nxml.gz-23
PMC3348565	PMC3348565.nxml.gz-24	[2621]	[2802]	However, the risk of repeated pneumonia in the subsequent 3 months was 13% (relative risk [RR] 0·78, 95% CI 0·64–0·94; p=0·01) lower in the vitamin D3compared with the placebo group	However	ANOMALY_CURIOUS_FINDING	[2621]	[2628]	PMC3348565.nxml.gz-26
PMC3348565	PMC3348565.nxml.gz-24	[2621]	[2802]	However, the risk of repeated pneumonia in the subsequent 3 months was 13% (relative risk [RR] 0·78, 95% CI 0·64–0·94; p=0·01) lower in the vitamin D3compared with the placebo group	However	ALTERNATIVE_OPTIONS_CONTROVERSY	[2621]	[2628]	PMC3348565.nxml.gz-25
PMC3348565	PMC3348565.nxml.gz-27	[2804]	[2940]	Other more recent studies assessing different outcomes in children or adults have conflicting findings on the effectiveness of vitamin D	Other	ALTERNATIVE_OPTIONS_CONTROVERSY	[2804]	[2809]	PMC3348565.nxml.gz-28
PMC3348565	PMC3348565.nxml.gz-27	[2804]	[2940]	Other more recent studies assessing different outcomes in children or adults have conflicting findings on the effectiveness of vitamin D	recent studies	INCOMPLETE_EVIDENCE	[2815]	[2829]	PMC3348565.nxml.gz-29
PMC3348565	PMC3348565.nxml.gz-27	[2804]	[2940]	Other more recent studies assessing different outcomes in children or adults have conflicting findings on the effectiveness of vitamin D	conflicting	ALTERNATIVE_OPTIONS_CONTROVERSY	[2886]	[2897]	PMC3348565.nxml.gz-30
PMC3348565	PMC3348565.nxml.gz-31	[2942]	[3218]	There is growing evidence of the vitamin D parancrine system enhancing innate immunity:4the activation of Toll-like receptors on monocytes and macrophages by microbial pathogens results in increased expression of CYP27B1 and vitamin D receptor ( VDR ) genes within these cells	growing evidence	INCOMPLETE_EVIDENCE	[2951]	[2967]	PMC3348565.nxml.gz-32
PMC3348565	PMC3348565.nxml.gz-33	[3697]	[3817]	It has been suggested that vitamin D might be used in the treatment of opportunistic and antibiotic-resistant infections	has been suggested	INCOMPLETE_EVIDENCE	[3700]	[3718]	PMC3348565.nxml.gz-34
PMC3348565	PMC3348565.nxml.gz-33	[3697]	[3817]	It has been suggested that vitamin D might be used in the treatment of opportunistic and antibiotic-resistant infections	might	INCOMPLETE_EVIDENCE	[3734]	[3739]	PMC3348565.nxml.gz-35
PMC3348565	PMC3348565.nxml.gz-36	[3819]	[3936]	There is debate between investigators regarding concentrations that relate to optimum stores of vitamin D in the body	debate	ALTERNATIVE_OPTIONS_CONTROVERSY	[3828]	[3834]	PMC3348565.nxml.gz-37
PMC3348565	PMC3348565.nxml.gz-36	[3819]	[3936]	There is debate between investigators regarding concentrations that relate to optimum stores of vitamin D in the body	relate	SUPERFICIAL_RELATIONSHIP	[3887]	[3893]	PMC3348565.nxml.gz-38
PMC3348565	PMC3348565.nxml.gz-39	[3938]	[4061]	In children, serum calcifediol concentrations should be maintained at 50 nmol/L (20 ng/mL) or greater for skeletal benefits	should be	FUTURE_WORK	[3984]	[3993]	PMC3348565.nxml.gz-40
PMC3348565	PMC3348565.nxml.gz-41	[4063]	[4282]	Vitamin D deficiency rickets in children younger than 5 years is an endemic problem in developing countries, ranging from 5–45%, even where sunlight is abundant,1,2,7,8and has also re-emerged in some developed countries	problem	PROBLEM_COMPLICATION	[4139]	[4146]	PMC3348565.nxml.gz-42
PMC3348565	PMC3348565.nxml.gz-41	[4063]	[4282]	Vitamin D deficiency rickets in children younger than 5 years is an endemic problem in developing countries, ranging from 5–45%, even where sunlight is abundant,1,2,7,8and has also re-emerged in some developed countries	even	ANOMALY_CURIOUS_FINDING	[4192]	[4196]	PMC3348565.nxml.gz-43
PMC3348565	PMC3348565.nxml.gz-41	[4063]	[4282]	Vitamin D deficiency rickets in children younger than 5 years is an endemic problem in developing countries, ranging from 5–45%, even where sunlight is abundant,1,2,7,8and has also re-emerged in some developed countries	some	INCOMPLETE_EVIDENCE	[4258]	[4262]	PMC3348565.nxml.gz-44
PMC3348565	PMC3348565.nxml.gz-46	[4595]	[4683]	Therefore, breastmilk, a normally poor source of vitamin D,11becomes even more deficient	Therefore	PROBABLE_UNDERSTANDING	[4595]	[4604]	PMC3348565.nxml.gz-45
PMC3348565	PMC3348565.nxml.gz-46	[4595]	[4683]	Therefore, breastmilk, a normally poor source of vitamin D,11becomes even more deficient	poor	PROBLEM_COMPLICATION	[4629]	[4633]	PMC3348565.nxml.gz-47
PMC3348565	PMC3348565.nxml.gz-46	[4595]	[4683]	Therefore, breastmilk, a normally poor source of vitamin D,11becomes even more deficient	even	ANOMALY_CURIOUS_FINDING	[4664]	[4668]	PMC3348565.nxml.gz-48
PMC3348565	PMC3348565.nxml.gz-49	[4685]	[4772]	Furthermore, the common practice of swaddling infants might reduce exposure to sunlight	might	INCOMPLETE_EVIDENCE	[4739]	[4744]	PMC3348565.nxml.gz-50
PMC3348565	PMC3348565.nxml.gz-52	[4774]	[4836]	Thus young children are at a high risk of vitamin D deficiency	Thus	PROBABLE_UNDERSTANDING	[4774]	[4778]	PMC3348565.nxml.gz-51
PMC3348565	PMC3348565.nxml.gz-53	[4838]	[5067]	A cross-sectional survey during the high-risk winter months in 2005 showed that greater than 95% of children younger than 5 years in a socioeconomically deprived part of Kabul had serum calcifediol levels of less than 37·5 nmol/L	showed	INCOMPLETE_EVIDENCE	[4906]	[4912]	PMC3348565.nxml.gz-14403
PMC3348565	PMC3348565.nxml.gz-56	[5071]	[5460]	On the basis of findings that vitamin D is an immunomodulator, that deficiency is a risk factor for pneumonia, and that quarterly supplementation had better compliance than daily or weekly supplementation,13,14we aimed to test the hypothesis that quarterly 100 000 IU vitamin D supplementation would reduce the incidence of radiologically confirmed pneumonia by 35% in our study population	On the basis of	INCOMPLETE_EVIDENCE	[5071]	[5086]	PMC3348565.nxml.gz-57
PMC3348565	PMC3348565.nxml.gz-56	[5071]	[5460]	On the basis of findings that vitamin D is an immunomodulator, that deficiency is a risk factor for pneumonia, and that quarterly supplementation had better compliance than daily or weekly supplementation,13,14we aimed to test the hypothesis that quarterly 100 000 IU vitamin D supplementation would reduce the incidence of radiologically confirmed pneumonia by 35% in our study population	aimed	QUESTION_ANSWERED_BY_THIS_WORK	[5284]	[5289]	PMC3348565.nxml.gz-58
PMC3348565	PMC3348565.nxml.gz-56	[5071]	[5460]	On the basis of findings that vitamin D is an immunomodulator, that deficiency is a risk factor for pneumonia, and that quarterly supplementation had better compliance than daily or weekly supplementation,13,14we aimed to test the hypothesis that quarterly 100 000 IU vitamin D supplementation would reduce the incidence of radiologically confirmed pneumonia by 35% in our study population	to test	QUESTION_ANSWERED_BY_THIS_WORK	[5290]	[5297]	PMC3348565.nxml.gz-59
PMC3348565	PMC3348565.nxml.gz-56	[5071]	[5460]	On the basis of findings that vitamin D is an immunomodulator, that deficiency is a risk factor for pneumonia, and that quarterly supplementation had better compliance than daily or weekly supplementation,13,14we aimed to test the hypothesis that quarterly 100 000 IU vitamin D supplementation would reduce the incidence of radiologically confirmed pneumonia by 35% in our study population	hypothesis	INCOMPLETE_EVIDENCE	[5302]	[5312]	PMC3348565.nxml.gz-60
PMC3348565	PMC3348565.nxml.gz-56	[5071]	[5460]	On the basis of findings that vitamin D is an immunomodulator, that deficiency is a risk factor for pneumonia, and that quarterly supplementation had better compliance than daily or weekly supplementation,13,14we aimed to test the hypothesis that quarterly 100 000 IU vitamin D supplementation would reduce the incidence of radiologically confirmed pneumonia by 35% in our study population	would	FUTURE_PREDICTION	[5365]	[5370]	PMC3348565.nxml.gz-61
PMC3348565	PMC3348565.nxml.gz-62	[5462]	[5665]	Our secondary hypotheses were that supplementation would reduce all pneumonias (radiologically confirmed or clinically defined), repeat episodes of pneumonia, hospital admissions, and all cause mortality	hypotheses	ALTERNATIVE_OPTIONS_CONTROVERSY	[5476]	[5486]	PMC3348565.nxml.gz-63
PMC3348565	PMC3348565.nxml.gz-62	[5462]	[5665]	Our secondary hypotheses were that supplementation would reduce all pneumonias (radiologically confirmed or clinically defined), repeat episodes of pneumonia, hospital admissions, and all cause mortality	would	FUTURE_PREDICTION	[5513]	[5518]	PMC3348565.nxml.gz-64
PMC3348565	PMC3348565.nxml.gz-65	[9057]	[9382]	We chose a quarterly supplementation regimen because in routine programme conditions a quarterly regimen is likely to have better adherence than a daily regimen,13,14and has been shown to be effective at maintaining the serum vitamin D concentration within normal ranges for 2–3 months in a French high-risk infant population	likely	PROBABLE_UNDERSTANDING	[9165]	[9171]	PMC3348565.nxml.gz-66
PMC3348565	PMC3348565.nxml.gz-65	[9057]	[9382]	We chose a quarterly supplementation regimen because in routine programme conditions a quarterly regimen is likely to have better adherence than a daily regimen,13,14and has been shown to be effective at maintaining the serum vitamin D concentration within normal ranges for 2–3 months in a French high-risk infant population	has been	INCOMPLETE_EVIDENCE	[9227]	[9235]	PMC3348565.nxml.gz-67
PMC3348565	PMC3348565.nxml.gz-72	[13359]	[13721]	We assumed that the incidence of the first or the only episode of pneumonia (first episode) in our placebo group would be 0·0585 per child per year based on the report that the incidence of acute lower respiratory infections in developing countries was greater than 0·65 per child per year,18that 12% of these episodes were pneumonia, and 75% were first episodes	assumed	PROBABLE_UNDERSTANDING	[13362]	[13369]	PMC3348565.nxml.gz-73
PMC3348565	PMC3348565.nxml.gz-72	[13359]	[13721]	We assumed that the incidence of the first or the only episode of pneumonia (first episode) in our placebo group would be 0·0585 per child per year based on the report that the incidence of acute lower respiratory infections in developing countries was greater than 0·65 per child per year,18that 12% of these episodes were pneumonia, and 75% were first episodes	would be	FUTURE_PREDICTION	[13472]	[13480]	PMC3348565.nxml.gz-74
PMC3348565	PMC3348565.nxml.gz-72	[13359]	[13721]	We assumed that the incidence of the first or the only episode of pneumonia (first episode) in our placebo group would be 0·0585 per child per year based on the report that the incidence of acute lower respiratory infections in developing countries was greater than 0·65 per child per year,18that 12% of these episodes were pneumonia, and 75% were first episodes	based on	INCOMPLETE_EVIDENCE	[13507]	[13515]	PMC3348565.nxml.gz-75
PMC3348565	PMC3348565.nxml.gz-76	[13723]	[14088]	Given that 73% of children had vitamin D deficiency in the study region in 2005,12and that the incidence of pneumonia was ten-times higher in vitamin D deficient children than in children without a deficiency in case-control studies1,2we postulated that there would be at least a 35% reduction in pneumonia incidence in the vitamin D compared with the placebo group	postulated	INCOMPLETE_EVIDENCE	[13961]	[13971]	PMC3348565.nxml.gz-78
PMC3348565	PMC3348565.nxml.gz-76	[13723]	[14088]	Given that 73% of children had vitamin D deficiency in the study region in 2005,12and that the incidence of pneumonia was ten-times higher in vitamin D deficient children than in children without a deficiency in case-control studies1,2we postulated that there would be at least a 35% reduction in pneumonia incidence in the vitamin D compared with the placebo group	would be	FUTURE_PREDICTION	[13983]	[13991]	PMC3348565.nxml.gz-79
PMC3348565	PMC3348565.nxml.gz-76	[13723]	[14088]	Given that 73% of children had vitamin D deficiency in the study region in 2005,12and that the incidence of pneumonia was ten-times higher in vitamin D deficient children than in children without a deficiency in case-control studies1,2we postulated that there would be at least a 35% reduction in pneumonia incidence in the vitamin D compared with the placebo group	at least	PROBABLE_UNDERSTANDING	[13992]	[14000]	PMC3348565.nxml.gz-80
PMC3348565	PMC3348565.nxml.gz-83	[14615]	[14756]	To assess the potential problem of multicollinearity we used Pearsons correlation coefficient or Cramers V (for paired categorical variables)	To assess	QUESTION_ANSWERED_BY_THIS_WORK	[14615]	[14624]	PMC3348565.nxml.gz-84
PMC3348565	PMC3348565.nxml.gz-83	[14615]	[14756]	To assess the potential problem of multicollinearity we used Pearsons correlation coefficient or Cramers V (for paired categorical variables)	potential	INCOMPLETE_EVIDENCE	[14629]	[14638]	PMC3348565.nxml.gz-85
PMC3348565	PMC3348565.nxml.gz-83	[14615]	[14756]	To assess the potential problem of multicollinearity we used Pearsons correlation coefficient or Cramers V (for paired categorical variables)	problem	PROBLEM_COMPLICATION	[14639]	[14646]	PMC3348565.nxml.gz-86
PMC3348565	PMC3348565.nxml.gz-87	[15745]	[15826]	We assessed violation of the proportionality assumption with Schoenfeld residuals	assessed	QUESTION_ANSWERED_BY_THIS_WORK	[15748]	[15756]	PMC3348565.nxml.gz-14405
PMC3348565	PMC3348565.nxml.gz-87	[15745]	[15826]	We assessed violation of the proportionality assumption with Schoenfeld residuals	violation	PROBLEM_COMPLICATION	[15757]	[15766]	PMC3348565.nxml.gz-88
PMC3348565	PMC3348565.nxml.gz-89	[16574]	[16694]	The difference was not statistically significant, although our study was not powered to detect differences in death rate	although	ALTERNATIVE_OPTIONS_CONTROVERSY	[16624]	[16632]	PMC3348565.nxml.gz-90
PMC3348565	PMC3348565.nxml.gz-89	[16574]	[16694]	The difference was not statistically significant, although our study was not powered to detect differences in death rate	not powered	DIFFICULT_TASK	[16647]	[16658]	PMC3348565.nxml.gz-92
PMC3348565	PMC3348565.nxml.gz-89	[16574]	[16694]	The difference was not statistically significant, although our study was not powered to detect differences in death rate	differences	ALTERNATIVE_OPTIONS_CONTROVERSY	[16669]	[16680]	PMC3348565.nxml.gz-93
PMC3348565	PMC3348565.nxml.gz-94	[17439]	[17647]	On intention-to-treat analysis, the incidence of the first episode of pneumonia was greater in the vitamin D rather than the placebo group, although this difference was not statistically significant (table 2)	although	ALTERNATIVE_OPTIONS_CONTROVERSY	[17579]	[17587]	PMC3348565.nxml.gz-96
PMC3348565	PMC3348565.nxml.gz-97	[18952]	[19250]	The mean serum calcifediol concentration was consistently and significantly higher in the vitamin D group than in the placebo group at 1 week, 4 weeks, and 3 months after administration of the first dose of vitamin D during the winter and at 2 weeks' post administration of dose 3 (spring;figure 3)	consistently	PROBABLE_UNDERSTANDING	[18997]	[19009]	PMC3348565.nxml.gz-98
PMC3348565	PMC3348565.nxml.gz-99	[19912]	[20280]	The ascertainment of study outcomes was robust, and done clinically through masked experienced and retrained paediatricians with Integrated Management of Childhood Illnesses clinical definitions of pneumonia applied in other trials18and radiologically through the interpretation of chest radiographs by masked, experienced, and external readers by use of WHO standards	robust	INCOMPLETE_EVIDENCE	[19952]	[19958]	PMC3348565.nxml.gz-100
PMC3348565	PMC3348565.nxml.gz-104	[20455]	[20605]	Thus the lack of a protective effect of vitamin D against pneumonia is probably not due to misclassification of outcomes or inadequate supplementation	Thus	PROBABLE_UNDERSTANDING	[20455]	[20459]	PMC3348565.nxml.gz-103
PMC3348565	PMC3348565.nxml.gz-104	[20455]	[20605]	Thus the lack of a protective effect of vitamin D against pneumonia is probably not due to misclassification of outcomes or inadequate supplementation	lack of	INCOMPLETE_EVIDENCE	[20464]	[20471]	PMC3348565.nxml.gz-105
PMC3348565	PMC3348565.nxml.gz-104	[20455]	[20605]	Thus the lack of a protective effect of vitamin D against pneumonia is probably not due to misclassification of outcomes or inadequate supplementation	protective	SUPERFICIAL_RELATIONSHIP	[20474]	[20484]	PMC3348565.nxml.gz-106
PMC3348565	PMC3348565.nxml.gz-104	[20455]	[20605]	Thus the lack of a protective effect of vitamin D against pneumonia is probably not due to misclassification of outcomes or inadequate supplementation	effect	SUPERFICIAL_RELATIONSHIP	[20485]	[20491]	PMC3348565.nxml.gz-107
PMC3348565	PMC3348565.nxml.gz-104	[20455]	[20605]	Thus the lack of a protective effect of vitamin D against pneumonia is probably not due to misclassification of outcomes or inadequate supplementation	probably	PROBABLE_UNDERSTANDING	[20526]	[20534]	PMC3348565.nxml.gz-108
PMC3348565	PMC3348565.nxml.gz-104	[20455]	[20605]	Thus the lack of a protective effect of vitamin D against pneumonia is probably not due to misclassification of outcomes or inadequate supplementation	misclassification	PROBLEM_COMPLICATION	[20546]	[20563]	PMC3348565.nxml.gz-110
PMC3348565	PMC3348565.nxml.gz-104	[20455]	[20605]	Thus the lack of a protective effect of vitamin D against pneumonia is probably not due to misclassification of outcomes or inadequate supplementation	inadequate	PROBLEM_COMPLICATION	[20579]	[20589]	PMC3348565.nxml.gz-111
PMC3348565	PMC3348565.nxml.gz-112	[20607]	[20994]	Any misclassification of other causes of raised respiratory rate as pneumonia, under-reporting, or over-reporting would be distributed equally between the two groups since the families, doctors, radiographers, radiologists, and data entry staff were masked to the randomisation groupings and the randomisation was successful since the characteristics were balanced between the two groups	misclassification	PROBLEM_COMPLICATION	[20611]	[20628]	PMC3348565.nxml.gz-113
PMC3348565	PMC3348565.nxml.gz-112	[20607]	[20994]	Any misclassification of other causes of raised respiratory rate as pneumonia, under-reporting, or over-reporting would be distributed equally between the two groups since the families, doctors, radiographers, radiologists, and data entry staff were masked to the randomisation groupings and the randomisation was successful since the characteristics were balanced between the two groups	other	ALTERNATIVE_OPTIONS_CONTROVERSY	[20632]	[20637]	PMC3348565.nxml.gz-114
PMC3348565	PMC3348565.nxml.gz-112	[20607]	[20994]	Any misclassification of other causes of raised respiratory rate as pneumonia, under-reporting, or over-reporting would be distributed equally between the two groups since the families, doctors, radiographers, radiologists, and data entry staff were masked to the randomisation groupings and the randomisation was successful since the characteristics were balanced between the two groups	would be	FUTURE_PREDICTION	[20721]	[20729]	PMC3348565.nxml.gz-115
PMC3348565	PMC3348565.nxml.gz-117	[20996]	[21182]	However, a limitation due to the high-risk nature of our population is that the generalisability of our findings to populations with low-to-moderate risk of vitamin deficiency is unknown	However	ALTERNATIVE_OPTIONS_CONTROVERSY	[20996]	[21003]	PMC3348565.nxml.gz-116
PMC3348565	PMC3348565.nxml.gz-117	[20996]	[21182]	However, a limitation due to the high-risk nature of our population is that the generalisability of our findings to populations with low-to-moderate risk of vitamin deficiency is unknown	limitation	INCOMPLETE_EVIDENCE	[21007]	[21017]	PMC3348565.nxml.gz-118
PMC3348565	PMC3348565.nxml.gz-117	[20996]	[21182]	However, a limitation due to the high-risk nature of our population is that the generalisability of our findings to populations with low-to-moderate risk of vitamin deficiency is unknown	due to	PROBLEM_COMPLICATION	[21018]	[21024]	PMC3348565.nxml.gz-119
PMC3348565	PMC3348565.nxml.gz-117	[20996]	[21182]	However, a limitation due to the high-risk nature of our population is that the generalisability of our findings to populations with low-to-moderate risk of vitamin deficiency is unknown	unknown	FULL_UNKNOWN	[21175]	[21182]	PMC3348565.nxml.gz-120
PMC3348565	PMC3348565.nxml.gz-14413	[21184]	[21315]	There were fewer deaths than we predicted in both groups, possibly due to the intense health surveillance possible during our study	fewer ... than ... predicted	ANOMALY_CURIOUS_FINDING	[21195, 21208, 21216]	[21200, 21212, 21225]	PMC3348565.nxml.gz-14407
PMC3348565	PMC3348565.nxml.gz-14413	[21184]	[21315]	There were fewer deaths than we predicted in both groups, possibly due to the intense health surveillance possible during our study	possibly	INCOMPLETE_EVIDENCE	[21242]	[21250]	PMC3348565.nxml.gz-123
PMC3348565	PMC3348565.nxml.gz-14413	[21184]	[21315]	There were fewer deaths than we predicted in both groups, possibly due to the intense health surveillance possible during our study	possible	INCOMPLETE_EVIDENCE	[21290]	[21298]	PMC3348565.nxml.gz-125
PMC3348565	PMC3348565.nxml.gz-126	[21317]	[21490]	Genotyping, which was not practical in our study setting, might have aided the interpretation of our findings, as shown in a vitamin D supplementation trial for tuberculosis	not practical	DIFFICULT_TASK	[21339]	[21352]	PMC3348565.nxml.gz-127
PMC3348565	PMC3348565.nxml.gz-126	[21317]	[21490]	Genotyping, which was not practical in our study setting, might have aided the interpretation of our findings, as shown in a vitamin D supplementation trial for tuberculosis	might	INCOMPLETE_EVIDENCE	[21375]	[21380]	PMC3348565.nxml.gz-128
PMC3348565	PMC3348565.nxml.gz-126	[21317]	[21490]	Genotyping, which was not practical in our study setting, might have aided the interpretation of our findings, as shown in a vitamin D supplementation trial for tuberculosis	interpretation	INCOMPLETE_EVIDENCE	[21396]	[21410]	PMC3348565.nxml.gz-129
PMC3348565	PMC3348565.nxml.gz-126	[21317]	[21490]	Genotyping, which was not practical in our study setting, might have aided the interpretation of our findings, as shown in a vitamin D supplementation trial for tuberculosis	as shown	INCOMPLETE_EVIDENCE	[21428]	[21436]	PMC3348565.nxml.gz-130
PMC3348565	PMC3348565.nxml.gz-131	[21494]	[21714]	We accounted for nutritional factors through a diet questionnaire, weight at recruitment, and growth comparison at the end of our study—any nutritional deficiencies would have been equally balanced between the two groups	would	FUTURE_PREDICTION	[21659]	[21664]	PMC3348565.nxml.gz-132
PMC3348565	PMC3348565.nxml.gz-131	[21494]	[21714]	We accounted for nutritional factors through a diet questionnaire, weight at recruitment, and growth comparison at the end of our study—any nutritional deficiencies would have been equally balanced between the two groups	have been	INCOMPLETE_EVIDENCE	[21665]	[21674]	PMC3348565.nxml.gz-133
PMC3348565	PMC3348565.nxml.gz-134	[21716]	[21929]	As with other studies, dietary calcium deficiency might have led to so-called wastage of body stores of vitamin D in both groups, affecting the maintenance of even higher vitamin D levels in the intervention group	As with other studies	INCOMPLETE_EVIDENCE	[21716]	[21737]	PMC3348565.nxml.gz-135
PMC3348565	PMC3348565.nxml.gz-134	[21716]	[21929]	As with other studies, dietary calcium deficiency might have led to so-called wastage of body stores of vitamin D in both groups, affecting the maintenance of even higher vitamin D levels in the intervention group	might	INCOMPLETE_EVIDENCE	[21766]	[21771]	PMC3348565.nxml.gz-136
PMC3348565	PMC3348565.nxml.gz-134	[21716]	[21929]	As with other studies, dietary calcium deficiency might have led to so-called wastage of body stores of vitamin D in both groups, affecting the maintenance of even higher vitamin D levels in the intervention group	affecting	SUPERFICIAL_RELATIONSHIP	[21846]	[21855]	PMC3348565.nxml.gz-137
PMC3348565	PMC3348565.nxml.gz-134	[21716]	[21929]	As with other studies, dietary calcium deficiency might have led to so-called wastage of body stores of vitamin D in both groups, affecting the maintenance of even higher vitamin D levels in the intervention group	even	ANOMALY_CURIOUS_FINDING	[21875]	[21879]	PMC3348565.nxml.gz-138
PMC3348565	PMC3348565.nxml.gz-140	[21931]	[22186]	Nevertheless, there was a higher (adequate level) mean serum concentration of calcifediol at the end of first supplementation period in the intervention group compared with the lower (not adequate) mean concentrations in the placebo group (data not shown)	Nevertheless	ALTERNATIVE_OPTIONS_CONTROVERSY	[21931]	[21943]	PMC3348565.nxml.gz-139
PMC3348565	PMC3348565.nxml.gz-141	[22188]	[22284]	Furthermore, adult fracture-outcome supplementation studies21show no benefit from adding calcium	show	INCOMPLETE_EVIDENCE	[22249]	[22253]	PMC3348565.nxml.gz-143
PMC3348565	PMC3348565.nxml.gz-144	[22286]	[22492]	A further limitation of our study is that it was not feasible to undertake biochemical assessment of the supplements or assess serum concentrations in all participants after each and between supplementation	limitation	INCOMPLETE_EVIDENCE	[22296]	[22306]	PMC3348565.nxml.gz-145
PMC3348565	PMC3348565.nxml.gz-144	[22286]	[22492]	A further limitation of our study is that it was not feasible to undertake biochemical assessment of the supplements or assess serum concentrations in all participants after each and between supplementation	not feasible	DIFFICULT_TASK	[22335]	[22347]	PMC3348565.nxml.gz-146
PMC3348565	PMC3348565.nxml.gz-148	[22494]	[22660]	Our sample testing suggest that the vitamin D group maintained above mean adequate vitamin D concetrations verses consistently low concentrations in the placebo group	suggest	INCOMPLETE_EVIDENCE	[22513]	[22520]	PMC3348565.nxml.gz-149
PMC3348565	PMC3348565.nxml.gz-148	[22494]	[22660]	Our sample testing suggest that the vitamin D group maintained above mean adequate vitamin D concetrations verses consistently low concentrations in the placebo group	consistently	PROBABLE_UNDERSTANDING	[22608]	[22620]	PMC3348565.nxml.gz-150
PMC3348565	PMC3348565.nxml.gz-151	[22662]	[22837]	It can be argued that a steady-state adequate vitamin D concentration was not reached in some children because of fluctuations in serum concentrations due to our study regimen	argued	INCOMPLETE_EVIDENCE	[22672]	[22678]	PMC3348565.nxml.gz-153
PMC3348565	PMC3348565.nxml.gz-151	[22662]	[22837]	It can be argued that a steady-state adequate vitamin D concentration was not reached in some children because of fluctuations in serum concentrations due to our study regimen	some	INCOMPLETE_EVIDENCE	[22751]	[22755]	PMC3348565.nxml.gz-154
PMC3348565	PMC3348565.nxml.gz-151	[22662]	[22837]	It can be argued that a steady-state adequate vitamin D concentration was not reached in some children because of fluctuations in serum concentrations due to our study regimen	because	PROBLEM_COMPLICATION	[22765]	[22772]	PMC3348565.nxml.gz-155
PMC3348565	PMC3348565.nxml.gz-151	[22662]	[22837]	It can be argued that a steady-state adequate vitamin D concentration was not reached in some children because of fluctuations in serum concentrations due to our study regimen	due to	PROBLEM_COMPLICATION	[22813]	[22819]	PMC3348565.nxml.gz-156
PMC3348565	PMC3348565.nxml.gz-158	[22839]	[23044]	Although this is probably true, a sufficient serum concentrations for the immunological effects of vitamin D is unknown and could be higher or lower than that of the skeletal system accepted concentrations	Although	ANOMALY_CURIOUS_FINDING	[22839]	[22847]	PMC3348565.nxml.gz-157
PMC3348565	PMC3348565.nxml.gz-158	[22839]	[23044]	Although this is probably true, a sufficient serum concentrations for the immunological effects of vitamin D is unknown and could be higher or lower than that of the skeletal system accepted concentrations	probably	PROBABLE_UNDERSTANDING	[22856]	[22864]	PMC3348565.nxml.gz-159
PMC3348565	PMC3348565.nxml.gz-158	[22839]	[23044]	Although this is probably true, a sufficient serum concentrations for the immunological effects of vitamin D is unknown and could be higher or lower than that of the skeletal system accepted concentrations	true	PROBABLE_UNDERSTANDING	[22865]	[22869]	PMC3348565.nxml.gz-160
PMC3348565	PMC3348565.nxml.gz-158	[22839]	[23044]	Although this is probably true, a sufficient serum concentrations for the immunological effects of vitamin D is unknown and could be higher or lower than that of the skeletal system accepted concentrations	effects	SUPERFICIAL_RELATIONSHIP	[22927]	[22934]	PMC3348565.nxml.gz-161
PMC3348565	PMC3348565.nxml.gz-158	[22839]	[23044]	Although this is probably true, a sufficient serum concentrations for the immunological effects of vitamin D is unknown and could be higher or lower than that of the skeletal system accepted concentrations	unknown	FULL_UNKNOWN	[22951]	[22958]	PMC3348565.nxml.gz-162
PMC3348565	PMC3348565.nxml.gz-158	[22839]	[23044]	Although this is probably true, a sufficient serum concentrations for the immunological effects of vitamin D is unknown and could be higher or lower than that of the skeletal system accepted concentrations	could be	INCOMPLETE_EVIDENCE	[22963]	[22971]	PMC3348565.nxml.gz-163
PMC3348565	PMC3348565.nxml.gz-165	[23046]	[23185]	The need for a steady state is currently highly speculative and relates to vitamin D2supplementation for negative cancer22and bone outcomes	The need	INCOMPLETE_EVIDENCE	[23046]	[23054]	PMC3348565.nxml.gz-164
PMC3348565	PMC3348565.nxml.gz-165	[23046]	[23185]	The need for a steady state is currently highly speculative and relates to vitamin D2supplementation for negative cancer22and bone outcomes	speculative	INCOMPLETE_EVIDENCE	[23094]	[23105]	PMC3348565.nxml.gz-166
PMC3348565	PMC3348565.nxml.gz-165	[23046]	[23185]	The need for a steady state is currently highly speculative and relates to vitamin D2supplementation for negative cancer22and bone outcomes	relates	SUPERFICIAL_RELATIONSHIP	[23110]	[23117]	PMC3348565.nxml.gz-167
PMC3348565	PMC3348565.nxml.gz-168	[23189]	[23499]	Our findings are at odds with smaller case-control hospital studies that show an enhanced rate of vitamin D deficiency or rickets in children with pneumonia and the increasing evidence suggesting that calcitriol, the biologically active metabolite of vitamin D, has an important role in the human immune system	at odds	ALTERNATIVE_OPTIONS_CONTROVERSY	[23206]	[23213]	PMC3348565.nxml.gz-169
PMC3348565	PMC3348565.nxml.gz-168	[23189]	[23499]	Our findings are at odds with smaller case-control hospital studies that show an enhanced rate of vitamin D deficiency or rickets in children with pneumonia and the increasing evidence suggesting that calcitriol, the biologically active metabolite of vitamin D, has an important role in the human immune system	smaller ... studies	INCOMPLETE_EVIDENCE	[23219, 23249]	[23226, 23256]	PMC3348565.nxml.gz-170
PMC3348565	PMC3348565.nxml.gz-168	[23189]	[23499]	Our findings are at odds with smaller case-control hospital studies that show an enhanced rate of vitamin D deficiency or rickets in children with pneumonia and the increasing evidence suggesting that calcitriol, the biologically active metabolite of vitamin D, has an important role in the human immune system	increasing evidence	INCOMPLETE_EVIDENCE	[23354]	[23373]	PMC3348565.nxml.gz-172
PMC3348565	PMC3348565.nxml.gz-168	[23189]	[23499]	Our findings are at odds with smaller case-control hospital studies that show an enhanced rate of vitamin D deficiency or rickets in children with pneumonia and the increasing evidence suggesting that calcitriol, the biologically active metabolite of vitamin D, has an important role in the human immune system	suggesting	INCOMPLETE_EVIDENCE	[23374]	[23384]	PMC3348565.nxml.gz-173
PMC3348565	PMC3348565.nxml.gz-168	[23189]	[23499]	Our findings are at odds with smaller case-control hospital studies that show an enhanced rate of vitamin D deficiency or rickets in children with pneumonia and the increasing evidence suggesting that calcitriol, the biologically active metabolite of vitamin D, has an important role in the human immune system	important	IMPORTANT_CONSIDERATION	[23458]	[23467]	PMC3348565.nxml.gz-174
PMC3348565	PMC3348565.nxml.gz-168	[23189]	[23499]	Our findings are at odds with smaller case-control hospital studies that show an enhanced rate of vitamin D deficiency or rickets in children with pneumonia and the increasing evidence suggesting that calcitriol, the biologically active metabolite of vitamin D, has an important role in the human immune system	role	SUPERFICIAL_RELATIONSHIP	[23468]	[23472]	PMC3348565.nxml.gz-175
PMC3348565	PMC3348565.nxml.gz-176	[23501]	[23680]	A systematic review of the role of vitamin D supplementation in infectious diseases had mixed findings, concluding that more rigorously designed clinical trials are needed (panel)	role	SUPERFICIAL_RELATIONSHIP	[23528]	[23532]	PMC3348565.nxml.gz-177
PMC3348565	PMC3348565.nxml.gz-176	[23501]	[23680]	A systematic review of the role of vitamin D supplementation in infectious diseases had mixed findings, concluding that more rigorously designed clinical trials are needed (panel)	mixed	ALTERNATIVE_OPTIONS_CONTROVERSY	[23589]	[23594]	PMC3348565.nxml.gz-178
PMC3348565	PMC3348565.nxml.gz-176	[23501]	[23680]	A systematic review of the role of vitamin D supplementation in infectious diseases had mixed findings, concluding that more rigorously designed clinical trials are needed (panel)	concluding	PROBABLE_UNDERSTANDING	[23605]	[23615]	PMC3348565.nxml.gz-179
PMC3348565	PMC3348565.nxml.gz-176	[23501]	[23680]	A systematic review of the role of vitamin D supplementation in infectious diseases had mixed findings, concluding that more rigorously designed clinical trials are needed (panel)	are needed	FUTURE_WORK	[23662]	[23672]	PMC3348565.nxml.gz-180
PMC3348565	PMC3348565.nxml.gz-181	[23683]	[23763]	No studies report the effect of vitamin D on radiologically confirmed pneumonias	No studies	INCOMPLETE_EVIDENCE	[23683]	[23693]	PMC3348565.nxml.gz-182
PMC3348565	PMC3348565.nxml.gz-181	[23683]	[23763]	No studies report the effect of vitamin D on radiologically confirmed pneumonias	effect	SUPERFICIAL_RELATIONSHIP	[23705]	[23711]	PMC3348565.nxml.gz-183
PMC3348565	PMC3348565.nxml.gz-185	[23765]	[24140]	Other trials assessing infections of the upper respiratory tract also had mixed findings: one trial in post-menopausal women26identified reduced self-reported episodes of infection of the upper respiratory tract, specifically in winter, whereas two others in elderly24and general adults27did not identify a difference between the groups with regards to self-reported episodes	Other	ALTERNATIVE_OPTIONS_CONTROVERSY	[23765]	[23770]	PMC3348565.nxml.gz-184
PMC3348565	PMC3348565.nxml.gz-185	[23765]	[24140]	Other trials assessing infections of the upper respiratory tract also had mixed findings: one trial in post-menopausal women26identified reduced self-reported episodes of infection of the upper respiratory tract, specifically in winter, whereas two others in elderly24and general adults27did not identify a difference between the groups with regards to self-reported episodes	mixed	ALTERNATIVE_OPTIONS_CONTROVERSY	[23839]	[23844]	PMC3348565.nxml.gz-186
PMC3348565	PMC3348565.nxml.gz-185	[23765]	[24140]	Other trials assessing infections of the upper respiratory tract also had mixed findings: one trial in post-menopausal women26identified reduced self-reported episodes of infection of the upper respiratory tract, specifically in winter, whereas two others in elderly24and general adults27did not identify a difference between the groups with regards to self-reported episodes	whereas	ALTERNATIVE_OPTIONS_CONTROVERSY	[24002]	[24009]	PMC3348565.nxml.gz-187
PMC3348565	PMC3348565.nxml.gz-188	[24142]	[24319]	One trial in schoolchildren28(measuring influenza A antigen from swabs) found a statistically significant reduced incidence in the intervention group (RR 0·58, 95% CI 0·34–0·99)	found	INCOMPLETE_EVIDENCE	[24214]	[24219]	PMC3348565.nxml.gz-189
PMC3348565	PMC3348565.nxml.gz-190	[24321]	[24391]	The benefits of supplementation for tuberculosis are similarly unclear	similarly	SUPERFICIAL_RELATIONSHIP	[24374]	[24383]	PMC3348565.nxml.gz-191
PMC3348565	PMC3348565.nxml.gz-190	[24321]	[24391]	The benefits of supplementation for tuberculosis are similarly unclear	unclear	FULL_UNKNOWN	[24384]	[24391]	PMC3348565.nxml.gz-192
PMC3348565	PMC3348565.nxml.gz-193	[24393]	[24838]	One paediatric trial showed 16% higher rates of tuberculosis symptom resolution,29an adult trial showed 23% greater sputum conversion rate at 6 months,30another trial showed 20% greater restriction of BCG-lux growth in blood,31another trial found accelerated sputum conversion only in a certain genotype of the sample,20whereas yet another found no significant difference in sputum conversion32in the intervention compared with the placebo group	One ... trial	INCOMPLETE_EVIDENCE	[24393, 24408]	[24396, 24413]	PMC3348565.nxml.gz-194
PMC3348565	PMC3348565.nxml.gz-193	[24393]	[24838]	One paediatric trial showed 16% higher rates of tuberculosis symptom resolution,29an adult trial showed 23% greater sputum conversion rate at 6 months,30another trial showed 20% greater restriction of BCG-lux growth in blood,31another trial found accelerated sputum conversion only in a certain genotype of the sample,20whereas yet another found no significant difference in sputum conversion32in the intervention compared with the placebo group	another trial	INCOMPLETE_EVIDENCE	[24546]	[24559]	PMC3348565.nxml.gz-14415
PMC3348565	PMC3348565.nxml.gz-193	[24393]	[24838]	One paediatric trial showed 16% higher rates of tuberculosis symptom resolution,29an adult trial showed 23% greater sputum conversion rate at 6 months,30another trial showed 20% greater restriction of BCG-lux growth in blood,31another trial found accelerated sputum conversion only in a certain genotype of the sample,20whereas yet another found no significant difference in sputum conversion32in the intervention compared with the placebo group	another trial	INCOMPLETE_EVIDENCE	[24620]	[24633]	PMC3348565.nxml.gz-14417
PMC3348565	PMC3348565.nxml.gz-193	[24393]	[24838]	One paediatric trial showed 16% higher rates of tuberculosis symptom resolution,29an adult trial showed 23% greater sputum conversion rate at 6 months,30another trial showed 20% greater restriction of BCG-lux growth in blood,31another trial found accelerated sputum conversion only in a certain genotype of the sample,20whereas yet another found no significant difference in sputum conversion32in the intervention compared with the placebo group	found	INCOMPLETE_EVIDENCE	[24634]	[24639]	PMC3348565.nxml.gz-196
PMC3348565	PMC3348565.nxml.gz-193	[24393]	[24838]	One paediatric trial showed 16% higher rates of tuberculosis symptom resolution,29an adult trial showed 23% greater sputum conversion rate at 6 months,30another trial showed 20% greater restriction of BCG-lux growth in blood,31another trial found accelerated sputum conversion only in a certain genotype of the sample,20whereas yet another found no significant difference in sputum conversion32in the intervention compared with the placebo group	only	INCOMPLETE_EVIDENCE	[24670]	[24674]	PMC3348565.nxml.gz-197
PMC3348565	PMC3348565.nxml.gz-193	[24393]	[24838]	One paediatric trial showed 16% higher rates of tuberculosis symptom resolution,29an adult trial showed 23% greater sputum conversion rate at 6 months,30another trial showed 20% greater restriction of BCG-lux growth in blood,31another trial found accelerated sputum conversion only in a certain genotype of the sample,20whereas yet another found no significant difference in sputum conversion32in the intervention compared with the placebo group	whereas	ALTERNATIVE_OPTIONS_CONTROVERSY	[24713]	[24720]	PMC3348565.nxml.gz-198
PMC3348565	PMC3348565.nxml.gz-193	[24393]	[24838]	One paediatric trial showed 16% higher rates of tuberculosis symptom resolution,29an adult trial showed 23% greater sputum conversion rate at 6 months,30another trial showed 20% greater restriction of BCG-lux growth in blood,31another trial found accelerated sputum conversion only in a certain genotype of the sample,20whereas yet another found no significant difference in sputum conversion32in the intervention compared with the placebo group	yet	ANOMALY_CURIOUS_FINDING	[24721]	[24724]	PMC3348565.nxml.gz-199
PMC3348565	PMC3348565.nxml.gz-193	[24393]	[24838]	One paediatric trial showed 16% higher rates of tuberculosis symptom resolution,29an adult trial showed 23% greater sputum conversion rate at 6 months,30another trial showed 20% greater restriction of BCG-lux growth in blood,31another trial found accelerated sputum conversion only in a certain genotype of the sample,20whereas yet another found no significant difference in sputum conversion32in the intervention compared with the placebo group	found	INCOMPLETE_EVIDENCE	[24733]	[24738]	PMC3348565.nxml.gz-200
PMC3348565	PMC3348565.nxml.gz-202	[24840]	[25074]	Vitamin D is linked with other non-bone health outcomes, but the few completed and adequately powered trials assessing the effect of supplementation have mixed findings in improving outcomes—ie, cancers, vascular disease, and diabetes	linked	SUPERFICIAL_RELATIONSHIP	[24853]	[24859]	PMC3348565.nxml.gz-203
PMC3348565	PMC3348565.nxml.gz-202	[24840]	[25074]	Vitamin D is linked with other non-bone health outcomes, but the few completed and adequately powered trials assessing the effect of supplementation have mixed findings in improving outcomes—ie, cancers, vascular disease, and diabetes	other	ALTERNATIVE_OPTIONS_CONTROVERSY	[24865]	[24870]	PMC3348565.nxml.gz-204
PMC3348565	PMC3348565.nxml.gz-202	[24840]	[25074]	Vitamin D is linked with other non-bone health outcomes, but the few completed and adequately powered trials assessing the effect of supplementation have mixed findings in improving outcomes—ie, cancers, vascular disease, and diabetes	few	INCOMPLETE_EVIDENCE	[24905]	[24908]	PMC3348565.nxml.gz-205
PMC3348565	PMC3348565.nxml.gz-202	[24840]	[25074]	Vitamin D is linked with other non-bone health outcomes, but the few completed and adequately powered trials assessing the effect of supplementation have mixed findings in improving outcomes—ie, cancers, vascular disease, and diabetes	effect	SUPERFICIAL_RELATIONSHIP	[24963]	[24969]	PMC3348565.nxml.gz-206
PMC3348565	PMC3348565.nxml.gz-202	[24840]	[25074]	Vitamin D is linked with other non-bone health outcomes, but the few completed and adequately powered trials assessing the effect of supplementation have mixed findings in improving outcomes—ie, cancers, vascular disease, and diabetes	mixed	ALTERNATIVE_OPTIONS_CONTROVERSY	[24994]	[24999]	PMC3348565.nxml.gz-207
PMC3348565	PMC3348565.nxml.gz-208	[25076]	[25319]	As in our studies, these inconsistent findings point to the existence of complicated pathways for the function of vitamin D in disease processes, or simply that the correct effective dose of vitamin D supplementation needs to be better defined	As in	INCOMPLETE_EVIDENCE	[25076]	[25081]	PMC3348565.nxml.gz-209
PMC3348565	PMC3348565.nxml.gz-208	[25076]	[25319]	As in our studies, these inconsistent findings point to the existence of complicated pathways for the function of vitamin D in disease processes, or simply that the correct effective dose of vitamin D supplementation needs to be better defined	inconsistent	ALTERNATIVE_OPTIONS_CONTROVERSY	[25101]	[25113]	PMC3348565.nxml.gz-210
PMC3348565	PMC3348565.nxml.gz-208	[25076]	[25319]	As in our studies, these inconsistent findings point to the existence of complicated pathways for the function of vitamin D in disease processes, or simply that the correct effective dose of vitamin D supplementation needs to be better defined	point	INCOMPLETE_EVIDENCE	[25123]	[25128]	PMC3348565.nxml.gz-211
PMC3348565	PMC3348565.nxml.gz-208	[25076]	[25319]	As in our studies, these inconsistent findings point to the existence of complicated pathways for the function of vitamin D in disease processes, or simply that the correct effective dose of vitamin D supplementation needs to be better defined	complicated	DIFFICULT_TASK	[25149]	[25160]	PMC3348565.nxml.gz-212
PMC3348565	PMC3348565.nxml.gz-208	[25076]	[25319]	As in our studies, these inconsistent findings point to the existence of complicated pathways for the function of vitamin D in disease processes, or simply that the correct effective dose of vitamin D supplementation needs to be better defined	needs	FUTURE_WORK	[25293]	[25298]	PMC3348565.nxml.gz-213
PMC3348565	PMC3348565.nxml.gz-208	[25076]	[25319]	As in our studies, these inconsistent findings point to the existence of complicated pathways for the function of vitamin D in disease processes, or simply that the correct effective dose of vitamin D supplementation needs to be better defined	better	INCOMPLETE_EVIDENCE	[25305]	[25311]	PMC3348565.nxml.gz-214
PMC3348565	PMC3348565.nxml.gz-215	[25321]	[25442]	The optimum concentrations of vitamin D for adults and children6are based on non-immunological and, mostly, bone outcomes	based on	SUPERFICIAL_RELATIONSHIP	[25389]	[25397]	PMC3348565.nxml.gz-216
PMC3348565	PMC3348565.nxml.gz-215	[25321]	[25442]	The optimum concentrations of vitamin D for adults and children6are based on non-immunological and, mostly, bone outcomes	mostly	PROBABLE_UNDERSTANDING	[25421]	[25427]	PMC3348565.nxml.gz-217
PMC3348565	PMC3348565.nxml.gz-218	[25444]	[25625]	An associated issue is that, after the start of our trial, speculations arose that high fluctuations of natural or supplemented vitamin D intake might be linked to negative outcomes	associated	SUPERFICIAL_RELATIONSHIP	[25447]	[25457]	PMC3348565.nxml.gz-219
PMC3348565	PMC3348565.nxml.gz-218	[25444]	[25625]	An associated issue is that, after the start of our trial, speculations arose that high fluctuations of natural or supplemented vitamin D intake might be linked to negative outcomes	issue	PROBLEM_COMPLICATION	[25458]	[25463]	PMC3348565.nxml.gz-220
PMC3348565	PMC3348565.nxml.gz-218	[25444]	[25625]	An associated issue is that, after the start of our trial, speculations arose that high fluctuations of natural or supplemented vitamin D intake might be linked to negative outcomes	speculations	INCOMPLETE_EVIDENCE	[25503]	[25515]	PMC3348565.nxml.gz-221
PMC3348565	PMC3348565.nxml.gz-218	[25444]	[25625]	An associated issue is that, after the start of our trial, speculations arose that high fluctuations of natural or supplemented vitamin D intake might be linked to negative outcomes	might	INCOMPLETE_EVIDENCE	[25589]	[25594]	PMC3348565.nxml.gz-222
PMC3348565	PMC3348565.nxml.gz-218	[25444]	[25625]	An associated issue is that, after the start of our trial, speculations arose that high fluctuations of natural or supplemented vitamin D intake might be linked to negative outcomes	linked	SUPERFICIAL_RELATIONSHIP	[25598]	[25604]	PMC3348565.nxml.gz-223
PMC3348565	PMC3348565.nxml.gz-224	[25627]	[25894]	These speculations relate two studies in which supplementation of a single large dose (300 00033or 500 00023IU) of vitamin D for reducing fractures in elderly women led to an increase in fractures, plus similar discrepancies in prostate cancer research with vitamin D	speculations	INCOMPLETE_EVIDENCE	[25633]	[25645]	PMC3348565.nxml.gz-225
PMC3348565	PMC3348565.nxml.gz-224	[25627]	[25894]	These speculations relate two studies in which supplementation of a single large dose (300 00033or 500 00023IU) of vitamin D for reducing fractures in elderly women led to an increase in fractures, plus similar discrepancies in prostate cancer research with vitamin D	relate	SUPERFICIAL_RELATIONSHIP	[25646]	[25652]	PMC3348565.nxml.gz-226
PMC3348565	PMC3348565.nxml.gz-224	[25627]	[25894]	These speculations relate two studies in which supplementation of a single large dose (300 00033or 500 00023IU) of vitamin D for reducing fractures in elderly women led to an increase in fractures, plus similar discrepancies in prostate cancer research with vitamin D	discrepancies	ALTERNATIVE_OPTIONS_CONTROVERSY	[25838]	[25851]	PMC3348565.nxml.gz-227
PMC3348565	PMC3348565.nxml.gz-228	[25897]	[26058]	Our findings and particularly the slightly higher repeat episodes of pneumonia in the vitamin D group could be due to such fluctuations if the hypothesis is true	could be	INCOMPLETE_EVIDENCE	[25999]	[26007]	PMC3348565.nxml.gz-229
PMC3348565	PMC3348565.nxml.gz-228	[25897]	[26058]	Our findings and particularly the slightly higher repeat episodes of pneumonia in the vitamin D group could be due to such fluctuations if the hypothesis is true	due to	PROBLEM_COMPLICATION	[26008]	[26014]	PMC3348565.nxml.gz-230
PMC3348565	PMC3348565.nxml.gz-228	[25897]	[26058]	Our findings and particularly the slightly higher repeat episodes of pneumonia in the vitamin D group could be due to such fluctuations if the hypothesis is true	if	ALTERNATIVE_OPTIONS_CONTROVERSY	[26033]	[26035]	PMC3348565.nxml.gz-231
PMC3348565	PMC3348565.nxml.gz-228	[25897]	[26058]	Our findings and particularly the slightly higher repeat episodes of pneumonia in the vitamin D group could be due to such fluctuations if the hypothesis is true	hypothesis	INCOMPLETE_EVIDENCE	[26040]	[26050]	PMC3348565.nxml.gz-232
PMC3348565	PMC3348565.nxml.gz-228	[25897]	[26058]	Our findings and particularly the slightly higher repeat episodes of pneumonia in the vitamin D group could be due to such fluctuations if the hypothesis is true	true	PROBABLE_UNDERSTANDING	[26054]	[26058]	PMC3348565.nxml.gz-233
PMC3348565	PMC3348565.nxml.gz-235	[26060]	[26558]	If so, then in terms of policy and guidelines, it is hard to know what regimen to recommend for future trials, given that clinical practice and evidence suggests that daily or weekly supplementations though ideal are not complied with13,14and are impractical for families, especially in developing countries, and food fortification at the population level will not be an option during exclusive breastfeeding periods (aged <6 months), nor is it likely to be adequate in highly deficient populations	If so	FUTURE_PREDICTION	[26060]	[26065]	PMC3348565.nxml.gz-234
PMC3348565	PMC3348565.nxml.gz-235	[26060]	[26558]	If so, then in terms of policy and guidelines, it is hard to know what regimen to recommend for future trials, given that clinical practice and evidence suggests that daily or weekly supplementations though ideal are not complied with13,14and are impractical for families, especially in developing countries, and food fortification at the population level will not be an option during exclusive breastfeeding periods (aged <6 months), nor is it likely to be adequate in highly deficient populations	what	EXPLICIT_QUESTION	[26126]	[26130]	PMC3348565.nxml.gz-236
PMC3348565	PMC3348565.nxml.gz-235	[26060]	[26558]	If so, then in terms of policy and guidelines, it is hard to know what regimen to recommend for future trials, given that clinical practice and evidence suggests that daily or weekly supplementations though ideal are not complied with13,14and are impractical for families, especially in developing countries, and food fortification at the population level will not be an option during exclusive breastfeeding periods (aged <6 months), nor is it likely to be adequate in highly deficient populations	recommend	FUTURE_WORK	[26142]	[26151]	PMC3348565.nxml.gz-237
PMC3348565	PMC3348565.nxml.gz-235	[26060]	[26558]	If so, then in terms of policy and guidelines, it is hard to know what regimen to recommend for future trials, given that clinical practice and evidence suggests that daily or weekly supplementations though ideal are not complied with13,14and are impractical for families, especially in developing countries, and food fortification at the population level will not be an option during exclusive breastfeeding periods (aged <6 months), nor is it likely to be adequate in highly deficient populations	future trials	FUTURE_WORK	[26156]	[26169]	PMC3348565.nxml.gz-238
PMC3348565	PMC3348565.nxml.gz-235	[26060]	[26558]	If so, then in terms of policy and guidelines, it is hard to know what regimen to recommend for future trials, given that clinical practice and evidence suggests that daily or weekly supplementations though ideal are not complied with13,14and are impractical for families, especially in developing countries, and food fortification at the population level will not be an option during exclusive breastfeeding periods (aged <6 months), nor is it likely to be adequate in highly deficient populations	suggests	INCOMPLETE_EVIDENCE	[26213]	[26221]	PMC3348565.nxml.gz-239
PMC3348565	PMC3348565.nxml.gz-235	[26060]	[26558]	If so, then in terms of policy and guidelines, it is hard to know what regimen to recommend for future trials, given that clinical practice and evidence suggests that daily or weekly supplementations though ideal are not complied with13,14and are impractical for families, especially in developing countries, and food fortification at the population level will not be an option during exclusive breastfeeding periods (aged <6 months), nor is it likely to be adequate in highly deficient populations	though	ANOMALY_CURIOUS_FINDING	[26260]	[26266]	PMC3348565.nxml.gz-240
PMC3348565	PMC3348565.nxml.gz-235	[26060]	[26558]	If so, then in terms of policy and guidelines, it is hard to know what regimen to recommend for future trials, given that clinical practice and evidence suggests that daily or weekly supplementations though ideal are not complied with13,14and are impractical for families, especially in developing countries, and food fortification at the population level will not be an option during exclusive breastfeeding periods (aged <6 months), nor is it likely to be adequate in highly deficient populations	ideal	IMPORTANT_CONSIDERATION	[26267]	[26272]	PMC3348565.nxml.gz-14419
PMC3348565	PMC3348565.nxml.gz-235	[26060]	[26558]	If so, then in terms of policy and guidelines, it is hard to know what regimen to recommend for future trials, given that clinical practice and evidence suggests that daily or weekly supplementations though ideal are not complied with13,14and are impractical for families, especially in developing countries, and food fortification at the population level will not be an option during exclusive breastfeeding periods (aged <6 months), nor is it likely to be adequate in highly deficient populations	impractical	DIFFICULT_TASK	[26307]	[26318]	PMC3348565.nxml.gz-242
PMC3348565	PMC3348565.nxml.gz-235	[26060]	[26558]	If so, then in terms of policy and guidelines, it is hard to know what regimen to recommend for future trials, given that clinical practice and evidence suggests that daily or weekly supplementations though ideal are not complied with13,14and are impractical for families, especially in developing countries, and food fortification at the population level will not be an option during exclusive breastfeeding periods (aged <6 months), nor is it likely to be adequate in highly deficient populations	will	FUTURE_PREDICTION	[26416]	[26420]	PMC3348565.nxml.gz-243
PMC3348565	PMC3348565.nxml.gz-235	[26060]	[26558]	If so, then in terms of policy and guidelines, it is hard to know what regimen to recommend for future trials, given that clinical practice and evidence suggests that daily or weekly supplementations though ideal are not complied with13,14and are impractical for families, especially in developing countries, and food fortification at the population level will not be an option during exclusive breastfeeding periods (aged <6 months), nor is it likely to be adequate in highly deficient populations	likely	PROBABLE_UNDERSTANDING	[26505]	[26511]	PMC3348565.nxml.gz-244
PMC3348565	PMC3348565.nxml.gz-246	[26560]	[26878]	Alternately, it might be that immunological effectiveness of supplementation is highly dependent upon other factors as yet unidentified, or other prevalent factors in this high-risk population (for example, other malnutrition factors and that 5·5% of the children in our study had a Z score of weight for age below −3)	Alternately	ALTERNATIVE_OPTIONS_CONTROVERSY	[26560]	[26571]	PMC3348565.nxml.gz-245
PMC3348565	PMC3348565.nxml.gz-246	[26560]	[26878]	Alternately, it might be that immunological effectiveness of supplementation is highly dependent upon other factors as yet unidentified, or other prevalent factors in this high-risk population (for example, other malnutrition factors and that 5·5% of the children in our study had a Z score of weight for age below −3)	might	INCOMPLETE_EVIDENCE	[26576]	[26581]	PMC3348565.nxml.gz-247
PMC3348565	PMC3348565.nxml.gz-246	[26560]	[26878]	Alternately, it might be that immunological effectiveness of supplementation is highly dependent upon other factors as yet unidentified, or other prevalent factors in this high-risk population (for example, other malnutrition factors and that 5·5% of the children in our study had a Z score of weight for age below −3)	dependent	SUPERFICIAL_RELATIONSHIP	[26647]	[26656]	PMC3348565.nxml.gz-248
PMC3348565	PMC3348565.nxml.gz-246	[26560]	[26878]	Alternately, it might be that immunological effectiveness of supplementation is highly dependent upon other factors as yet unidentified, or other prevalent factors in this high-risk population (for example, other malnutrition factors and that 5·5% of the children in our study had a Z score of weight for age below −3)	other	ALTERNATIVE_OPTIONS_CONTROVERSY	[26662]	[26667]	PMC3348565.nxml.gz-249
PMC3348565	PMC3348565.nxml.gz-246	[26560]	[26878]	Alternately, it might be that immunological effectiveness of supplementation is highly dependent upon other factors as yet unidentified, or other prevalent factors in this high-risk population (for example, other malnutrition factors and that 5·5% of the children in our study had a Z score of weight for age below −3)	yet	ANOMALY_CURIOUS_FINDING	[26679]	[26682]	PMC3348565.nxml.gz-250
PMC3348565	PMC3348565.nxml.gz-246	[26560]	[26878]	Alternately, it might be that immunological effectiveness of supplementation is highly dependent upon other factors as yet unidentified, or other prevalent factors in this high-risk population (for example, other malnutrition factors and that 5·5% of the children in our study had a Z score of weight for age below −3)	unidentified	FULL_UNKNOWN	[26683]	[26695]	PMC3348565.nxml.gz-251
PMC3348565	PMC3348565.nxml.gz-246	[26560]	[26878]	Alternately, it might be that immunological effectiveness of supplementation is highly dependent upon other factors as yet unidentified, or other prevalent factors in this high-risk population (for example, other malnutrition factors and that 5·5% of the children in our study had a Z score of weight for age below −3)	other	ALTERNATIVE_OPTIONS_CONTROVERSY	[26700]	[26705]	PMC3348565.nxml.gz-252
PMC3348565	PMC3348565.nxml.gz-246	[26560]	[26878]	Alternately, it might be that immunological effectiveness of supplementation is highly dependent upon other factors as yet unidentified, or other prevalent factors in this high-risk population (for example, other malnutrition factors and that 5·5% of the children in our study had a Z score of weight for age below −3)	other	ALTERNATIVE_OPTIONS_CONTROVERSY	[26767]	[26772]	PMC3348565.nxml.gz-253
PMC3348565	PMC3348565.nxml.gz-255	[26880]	[27210]	Further questions arise with respect to the previous treatment trial in the same region of Kabul, which showed that a single high-dose supplementation with 100 000 IU vitamin D3given orally to young children, along with antibiotic treatment at the time of diagnosis, reduced repeat episodes of pneumonia in the subsequent 3 months	Further questions	FUTURE_WORK	[26880]	[26897]	PMC3348565.nxml.gz-254
PMC3348565	PMC3348565.nxml.gz-256	[27212]	[27512]	The inconsistent results could be related to the evidence that stimulation of Toll-like receptors on macrophages and monocytes by bacterial antigens is important in up-regulation of CYP27B1 and the vitamin D receptor,5which are crucial in production of cathelicidins in vitamin-D-depleted individuals	inconsistent	ALTERNATIVE_OPTIONS_CONTROVERSY	[27216]	[27228]	PMC3348565.nxml.gz-257
PMC3348565	PMC3348565.nxml.gz-256	[27212]	[27512]	The inconsistent results could be related to the evidence that stimulation of Toll-like receptors on macrophages and monocytes by bacterial antigens is important in up-regulation of CYP27B1 and the vitamin D receptor,5which are crucial in production of cathelicidins in vitamin-D-depleted individuals	could be	INCOMPLETE_EVIDENCE	[27237]	[27245]	PMC3348565.nxml.gz-258
PMC3348565	PMC3348565.nxml.gz-256	[27212]	[27512]	The inconsistent results could be related to the evidence that stimulation of Toll-like receptors on macrophages and monocytes by bacterial antigens is important in up-regulation of CYP27B1 and the vitamin D receptor,5which are crucial in production of cathelicidins in vitamin-D-depleted individuals	related	SUPERFICIAL_RELATIONSHIP	[27246]	[27253]	PMC3348565.nxml.gz-259
PMC3348565	PMC3348565.nxml.gz-256	[27212]	[27512]	The inconsistent results could be related to the evidence that stimulation of Toll-like receptors on macrophages and monocytes by bacterial antigens is important in up-regulation of CYP27B1 and the vitamin D receptor,5which are crucial in production of cathelicidins in vitamin-D-depleted individuals	important	IMPORTANT_CONSIDERATION	[27364]	[27373]	PMC3348565.nxml.gz-260
PMC3348565	PMC3348565.nxml.gz-256	[27212]	[27512]	The inconsistent results could be related to the evidence that stimulation of Toll-like receptors on macrophages and monocytes by bacterial antigens is important in up-regulation of CYP27B1 and the vitamin D receptor,5which are crucial in production of cathelicidins in vitamin-D-depleted individuals	crucial	IMPORTANT_CONSIDERATION	[27440]	[27447]	PMC3348565.nxml.gz-261
PMC3348565	PMC3348565.nxml.gz-262	[27514]	[27654]	In other words, this system might not be effective unless there is existing infection with pathogens when vitamin D supplementation is given	might	INCOMPLETE_EVIDENCE	[27542]	[27547]	PMC3348565.nxml.gz-263
PMC3348565	PMC3348565.nxml.gz-264	[27656]	[27868]	Finally, any possible reduction in the incidence of pneumonia in our trial might be restricted to only certain genotypes as recorded in a single tt genotype after the start of our trial in a study of tuberculosis	possible	INCOMPLETE_EVIDENCE	[27669]	[27677]	PMC3348565.nxml.gz-265
PMC3348565	PMC3348565.nxml.gz-264	[27656]	[27868]	Finally, any possible reduction in the incidence of pneumonia in our trial might be restricted to only certain genotypes as recorded in a single tt genotype after the start of our trial in a study of tuberculosis	might	INCOMPLETE_EVIDENCE	[27731]	[27736]	PMC3348565.nxml.gz-266
PMC3348565	PMC3348565.nxml.gz-264	[27656]	[27868]	Finally, any possible reduction in the incidence of pneumonia in our trial might be restricted to only certain genotypes as recorded in a single tt genotype after the start of our trial in a study of tuberculosis	only	INCOMPLETE_EVIDENCE	[27754]	[27758]	PMC3348565.nxml.gz-267
PMC3348565	PMC3348565.nxml.gz-268	[27871]	[28107]	Both the pneumonia treatment and the population supplementation trials need to be repeated in other settings for confirmation, and frequent determination of serum calcifediol concentrations might guide the interpretation of the findings	need to be	FUTURE_WORK	[27942]	[27952]	PMC3348565.nxml.gz-269
PMC3348565	PMC3348565.nxml.gz-268	[27871]	[28107]	Both the pneumonia treatment and the population supplementation trials need to be repeated in other settings for confirmation, and frequent determination of serum calcifediol concentrations might guide the interpretation of the findings	other	ALTERNATIVE_OPTIONS_CONTROVERSY	[27965]	[27970]	PMC3348565.nxml.gz-272
PMC3348565	PMC3348565.nxml.gz-268	[27871]	[28107]	Both the pneumonia treatment and the population supplementation trials need to be repeated in other settings for confirmation, and frequent determination of serum calcifediol concentrations might guide the interpretation of the findings	confirmation	INCOMPLETE_EVIDENCE	[27984]	[27996]	PMC3348565.nxml.gz-273
PMC3348565	PMC3348565.nxml.gz-268	[27871]	[28107]	Both the pneumonia treatment and the population supplementation trials need to be repeated in other settings for confirmation, and frequent determination of serum calcifediol concentrations might guide the interpretation of the findings	might	INCOMPLETE_EVIDENCE	[28061]	[28066]	PMC3348565.nxml.gz-274
PMC3348565	PMC3348565.nxml.gz-268	[27871]	[28107]	Both the pneumonia treatment and the population supplementation trials need to be repeated in other settings for confirmation, and frequent determination of serum calcifediol concentrations might guide the interpretation of the findings	interpretation	INCOMPLETE_EVIDENCE	[28077]	[28091]	PMC3348565.nxml.gz-275
PMC3348565	PMC3348565.nxml.gz-277	[28109]	[28272]	As with the trials in the older children, giving higher doses of vitamin D,25,34we too did not record any adverse effects associated with vitamin D supplementation	As with	INCOMPLETE_EVIDENCE	[28109]	[28116]	PMC3348565.nxml.gz-276
PMC3348565	PMC3348565.nxml.gz-281	[28274]	[28410]	However, the number of children and the length of follow-up involved in these studies could only detect common and early adverse effects	However	ALTERNATIVE_OPTIONS_CONTROVERSY	[28274]	[28281]	PMC3348565.nxml.gz-280
PMC3348565	PMC3348565.nxml.gz-281	[28274]	[28410]	However, the number of children and the length of follow-up involved in these studies could only detect common and early adverse effects	involved	SUPERFICIAL_RELATIONSHIP	[28334]	[28342]	PMC3348565.nxml.gz-282
PMC3348565	PMC3348565.nxml.gz-281	[28274]	[28410]	However, the number of children and the length of follow-up involved in these studies could only detect common and early adverse effects	could	INCOMPLETE_EVIDENCE	[28360]	[28365]	PMC3348565.nxml.gz-283
PMC3348565	PMC3348565.nxml.gz-281	[28274]	[28410]	However, the number of children and the length of follow-up involved in these studies could only detect common and early adverse effects	only	INCOMPLETE_EVIDENCE	[28366]	[28370]	PMC3348565.nxml.gz-284
PMC3348565	PMC3348565.nxml.gz-281	[28274]	[28410]	However, the number of children and the length of follow-up involved in these studies could only detect common and early adverse effects	effects	SUPERFICIAL_RELATIONSHIP	[28403]	[28410]	PMC3348565.nxml.gz-285
PMC3348565	PMC3348565.nxml.gz-286	[28412]	[28679]	Although vitamin D overload is a theoretical possibility, 100 000 IU of vitamin D3has been shown to provide the best protection against vitamin D deficiency without overload or side-effects in high-risk infants aged 0–9 months with normal baseline ranges of vitamin D	Although	ALTERNATIVE_OPTIONS_CONTROVERSY	[28412]	[28420]	PMC3348565.nxml.gz-287
PMC3348565	PMC3348565.nxml.gz-286	[28412]	[28679]	Although vitamin D overload is a theoretical possibility, 100 000 IU of vitamin D3has been shown to provide the best protection against vitamin D deficiency without overload or side-effects in high-risk infants aged 0–9 months with normal baseline ranges of vitamin D	possibility	INCOMPLETE_EVIDENCE	[28457]	[28468]	PMC3348565.nxml.gz-289
PMC3348565	PMC3348565.nxml.gz-286	[28412]	[28679]	Although vitamin D overload is a theoretical possibility, 100 000 IU of vitamin D3has been shown to provide the best protection against vitamin D deficiency without overload or side-effects in high-risk infants aged 0–9 months with normal baseline ranges of vitamin D	has been	INCOMPLETE_EVIDENCE	[28494]	[28502]	PMC3348565.nxml.gz-290
PMC3348565	PMC3348565.nxml.gz-291	[28892]	[29296]	Higher than recommended doses of daily supplementation of vitamin D (500–1000 IU per day, adding up to 120 000 IU over 3 months) plus additional milk fortified with vitamin D, has been shown not to induce an overload,13including in infants starting with normal ranges of vitamin D, even when supplementation continued during the summer (in France) and when mothers had antenatal vitamin D supplementation	recommended	FUTURE_WORK	[28904]	[28915]	PMC3348565.nxml.gz-293
PMC3348565	PMC3348565.nxml.gz-291	[28892]	[29296]	Higher than recommended doses of daily supplementation of vitamin D (500–1000 IU per day, adding up to 120 000 IU over 3 months) plus additional milk fortified with vitamin D, has been shown not to induce an overload,13including in infants starting with normal ranges of vitamin D, even when supplementation continued during the summer (in France) and when mothers had antenatal vitamin D supplementation	has been	INCOMPLETE_EVIDENCE	[29068]	[29076]	PMC3348565.nxml.gz-294
PMC3348565	PMC3348565.nxml.gz-291	[28892]	[29296]	Higher than recommended doses of daily supplementation of vitamin D (500–1000 IU per day, adding up to 120 000 IU over 3 months) plus additional milk fortified with vitamin D, has been shown not to induce an overload,13including in infants starting with normal ranges of vitamin D, even when supplementation continued during the summer (in France) and when mothers had antenatal vitamin D supplementation	even	ANOMALY_CURIOUS_FINDING	[29174]	[29178]	PMC3348565.nxml.gz-295
PMC3348565	PMC3348565.nxml.gz-296	[29299]	[29543]	It is important to note that in our study, where community supplementation was in a population with known high rates of vitamin D deficiency, 1% of children tested had a calcifediol concentration greater than 375 nmol/L—thought undesirably high	important	IMPORTANT_CONSIDERATION	[29305]	[29314]	PMC3348565.nxml.gz-297
PMC3348565	PMC3348565.nxml.gz-296	[29299]	[29543]	It is important to note that in our study, where community supplementation was in a population with known high rates of vitamin D deficiency, 1% of children tested had a calcifediol concentration greater than 375 nmol/L—thought undesirably high	thought	INCOMPLETE_EVIDENCE	[29519]	[29526]	PMC3348565.nxml.gz-298
PMC3348565	PMC3348565.nxml.gz-296	[29299]	[29543]	It is important to note that in our study, where community supplementation was in a population with known high rates of vitamin D deficiency, 1% of children tested had a calcifediol concentration greater than 375 nmol/L—thought undesirably high	undesirably	PROBLEM_COMPLICATION	[29527]	[29538]	PMC3348565.nxml.gz-299
PMC3348565	PMC3348565.nxml.gz-301	[29545]	[29694]	Although these did not produce any clinical signs and symptoms, these measurements raise a need for caution with doses for population supplementation	Although	ANOMALY_CURIOUS_FINDING	[29545]	[29553]	PMC3348565.nxml.gz-300
PMC3348565	PMC3348565.nxml.gz-301	[29545]	[29694]	Although these did not produce any clinical signs and symptoms, these measurements raise a need for caution with doses for population supplementation	need	FUTURE_WORK	[29636]	[29640]	PMC3348565.nxml.gz-302
PMC3348565	PMC3348565.nxml.gz-301	[29545]	[29694]	Although these did not produce any clinical signs and symptoms, these measurements raise a need for caution with doses for population supplementation	caution	IMPORTANT_CONSIDERATION	[29645]	[29652]	PMC3348565.nxml.gz-303
PMC3348565	PMC3348565.nxml.gz-305	[29696]	[29826]	The speculative negative role of fluctuations is vitamin D needs to be considered with caution until further evidence is available	speculative	INCOMPLETE_EVIDENCE	[29700]	[29711]	PMC3348565.nxml.gz-306
PMC3348565	PMC3348565.nxml.gz-305	[29696]	[29826]	The speculative negative role of fluctuations is vitamin D needs to be considered with caution until further evidence is available	role	SUPERFICIAL_RELATIONSHIP	[29721]	[29725]	PMC3348565.nxml.gz-307
PMC3348565	PMC3348565.nxml.gz-305	[29696]	[29826]	The speculative negative role of fluctuations is vitamin D needs to be considered with caution until further evidence is available	needs	FUTURE_WORK	[29755]	[29760]	PMC3348565.nxml.gz-308
PMC3348565	PMC3348565.nxml.gz-305	[29696]	[29826]	The speculative negative role of fluctuations is vitamin D needs to be considered with caution until further evidence is available	considered	FUTURE_WORK	[29767]	[29777]	PMC3348565.nxml.gz-309
PMC3348565	PMC3348565.nxml.gz-305	[29696]	[29826]	The speculative negative role of fluctuations is vitamin D needs to be considered with caution until further evidence is available	caution	INCOMPLETE_EVIDENCE	[29783]	[29790]	PMC3348565.nxml.gz-310
PMC3348565	PMC3348565.nxml.gz-305	[29696]	[29826]	The speculative negative role of fluctuations is vitamin D needs to be considered with caution until further evidence is available	until	FUTURE_WORK	[29791]	[29796]	PMC3348565.nxml.gz-311
PMC3348565	PMC3348565.nxml.gz-305	[29696]	[29826]	The speculative negative role of fluctuations is vitamin D needs to be considered with caution until further evidence is available	further evidence	INCOMPLETE_EVIDENCE	[29797]	[29813]	PMC3348565.nxml.gz-312
PMC3348565	PMC3348565.nxml.gz-313	[29828]	[30002]	We have shown that a quarterly 100 000 IU supplementation of vitamin D3did not reduce the incidence of pneumonias in children living in regions with high vitamin D deficiency	have shown	INCOMPLETE_EVIDENCE	[29831]	[29841]	PMC3348565.nxml.gz-314
PMC3348565	PMC3348565.nxml.gz-14426	[30004]	[30206]	In populations with similar characteristics, quarterly population level supplementation of vitamin D to infants and young children is not a policy option for reducing the burden of pneumonia in children	is not ... option	DIFFICULT_TASK	[30135, 30151]	[30141, 30157]	PMC3348565.nxml.gz-14423
PMC3348565	PMC3348565.nxml.gz-14426	[30004]	[30206]	In populations with similar characteristics, quarterly population level supplementation of vitamin D to infants and young children is not a policy option for reducing the burden of pneumonia in children	the burden	IMPORTANT_CONSIDERATION	[30171]	[30181]	PMC3348565.nxml.gz-14421
